• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型咪唑并[2,1-b]噻唑类抗癌剂作为潜在的粘着斑激酶抑制剂:合成、计算机模拟和体外评价。

Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation.

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, European University of Lefke, Northern Cyprus, Turkey.

出版信息

Chem Biol Drug Des. 2021 Aug;98(2):270-282. doi: 10.1111/cbdd.13896. Epub 2021 Jun 12.

DOI:10.1111/cbdd.13896
PMID:34021971
Abstract

The purpose of this study was to synthesize imidazo[2,1-b]thiazole derivatives, characterize them with spectroscopical techniques and investigate for cytotoxic and apoptotic effects on glioma C6 cancer cell line. The in vitro anticancer activities were also investigated against focal adhesion kinase. Most of the compounds, particularly the derivatives carrying 3-oxo-1-tiya-4-azaspiro[4.5]decane moiety, exhibited higher or comparable activities in comparison with the reference drug, cisplatin. Compounds with methyl, propyl, phenyl moieties at the eighth and second position of the spirothiazolidinone ring showed high FAK inhibitory activities. In addition, molecular docking studies shed light on the binding modes of the synthesized compounds. The critical interactions with amino acid residues located in the active site were revealed. The results obtained from both biological assay data and computational results might provide insight into developing new inhibitors against focal adhesion kinase.

摘要

本研究旨在合成咪唑并[2,1-b]噻唑衍生物,用光谱技术对其进行表征,并研究其对神经胶质瘤 C6 癌细胞系的细胞毒性和凋亡作用。还研究了它们对粘着斑激酶的体外抗癌活性。大多数化合物,特别是带有 3-氧代-1-硫杂-4-氮杂螺[4.5]癸烷部分的衍生物,表现出比参考药物顺铂更高或相当的活性。在螺噻唑烷酮环的第八位和第二位带有甲基、丙基、苯基部分的化合物表现出高的粘着斑激酶抑制活性。此外,分子对接研究揭示了合成化合物的结合模式。揭示了与位于活性部位的氨基酸残基的关键相互作用。从生物测定数据和计算结果中获得的结果可能为开发针对粘着斑激酶的新型抑制剂提供思路。

相似文献

1
Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation.新型咪唑并[2,1-b]噻唑类抗癌剂作为潜在的粘着斑激酶抑制剂:合成、计算机模拟和体外评价。
Chem Biol Drug Des. 2021 Aug;98(2):270-282. doi: 10.1111/cbdd.13896. Epub 2021 Jun 12.
2
Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.新型合成 BRAF 抑制剂具有 5-(嘧啶-4-基)咪唑并[2,1-b]噻唑骨架的抗癌特性。
Bioorg Med Chem. 2019 May 15;27(10):2041-2051. doi: 10.1016/j.bmc.2019.03.062. Epub 2019 Apr 2.
3
Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening.通过对咪唑并噻唑衍生物的结构优化,得到了一个新的有前景的系列作为 B-Raf V600E 抑制剂;合成、体外测定和计算机筛选。
Bioorg Chem. 2020 Jul;100:103967. doi: 10.1016/j.bioorg.2020.103967. Epub 2020 May 22.
4
Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity.新型咪唑并[1,2-a][1,3,5]三嗪及其衍生物的设计、合成与评价作为具有抗肿瘤活性的粘着斑激酶抑制剂。
J Med Chem. 2015 Jan 8;58(1):237-51. doi: 10.1021/jm500784e. Epub 2014 Sep 11.
5
Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.含1,4-苯并二氧六环部分的新型2-苯乙烯基-5-硝基咪唑衍生物作为具有抗癌活性的粘着斑激酶(FAK)抑制剂的合成、生物学评价及分子对接研究
Bioorg Med Chem. 2014 Jun 1;22(11):2947-54. doi: 10.1016/j.bmc.2014.04.005. Epub 2014 Apr 13.
6
Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.评价咪唑并[2,1-b]噻唑类抗癌剂在十年间(2011-2020 年)的发展:现状与未来展望。
Bioorg Med Chem. 2021 Jan 1;29:115897. doi: 10.1016/j.bmc.2020.115897. Epub 2020 Nov 28.
7
Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors.设计、合成及生物评价 2,3-二氢咪唑并[2,1-b]噻唑类化合物作为双重 EGFR 和 IGF1R 抑制剂。
Bioorg Chem. 2021 Oct;115:105151. doi: 10.1016/j.bioorg.2021.105151. Epub 2021 Jul 7.
8
Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.含吡唑基团的新型咪唑并[2,1-b]噻唑衍生物的合成、体外抗癌评估及计算机模拟研究
Eur J Med Chem. 2014 Mar 21;75:492-500. doi: 10.1016/j.ejmech.2013.12.010. Epub 2014 Jan 23.
9
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.发现 7H-吡咯并[2,3-d]嘧啶衍生物作为有效的 FAK 抑制剂:设计、合成、生物评价和分子对接研究。
Bioorg Chem. 2020 Sep;102:104092. doi: 10.1016/j.bioorg.2020.104092. Epub 2020 Jul 14.
10
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.新型含苯并三唑部分的 1,3,4-噁二唑衍生物的合成、生物评价及分子对接研究作为具有抗癌活性的 FAK 抑制剂。
Bioorg Med Chem. 2013 Jul 1;21(13):3723-9. doi: 10.1016/j.bmc.2013.04.043. Epub 2013 Apr 23.

引用本文的文献

1
Experimental and Computational Investigation of Cu(II) and Zn(II) complexes: DFT, Docking, and Anti-Lung Cancer Studies.铜(II)和锌(II)配合物的实验与计算研究:密度泛函理论、对接及抗肺癌研究
Future Med Chem. 2025 Mar;17(6):669-679. doi: 10.1080/17568919.2025.2478815. Epub 2025 Mar 21.
2
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.新型嘧啶连接化合物的设计、合成及抗癌作用机制评估
Pharmaceuticals (Basel). 2025 Feb 19;18(2):270. doi: 10.3390/ph18020270.
3
Recent studies on protein kinase signaling inhibitors based on thiazoles: review to date.
基于噻唑的蛋白激酶信号传导抑制剂的近期研究:迄今综述
RSC Adv. 2024 Nov 19;14(50):36989-37018. doi: 10.1039/d4ra05601a.
4
Design, synthesis, pharmacological evaluation, and studies of the activity of novel spiro pyrrolo[3,4-]pyrimidine derivatives.新型螺环吡咯并[3,4-c]嘧啶衍生物的设计、合成、药理评价及活性研究
RSC Adv. 2024 Jan 2;14(2):995-1008. doi: 10.1039/d3ra07078f.
5
Synthesis, biological evaluation and molecular docking studies of novel 1,3,4-thiadiazoles as potential anticancer agents and human carbonic anhydrase inhibitors.新型1,3,4-噻二唑作为潜在抗癌剂和人碳酸酐酶抑制剂的合成、生物学评价及分子对接研究
Mol Divers. 2024 Dec;28(6):3801-3815. doi: 10.1007/s11030-023-10778-5. Epub 2023 Dec 20.